$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What is the mechanism of action of dacomitinib? How does it exert its therapeutic effects through pharmacological effects?
2026-02-01 22:25:32
Check Details
Efficacy of Bangladeshi version of brigatinib and comparison with other versions
2026-02-01 22:25:32
Check Details
What are the indications for entrectinib? What patients and disease types is it suitable for?
2026-02-01 22:25:32
Check Details
Are acalatinib and acotinib the same? What are the differences between these two medications?
2026-02-01 22:25:32
Check Details
How many pills of ibrutinib should be taken a day? Is it necessary to adjust the daily dosage according to different conditions?
2026-02-01 22:25:32
Check Details
How long does it take to see the effects of ruxolitinib tablets? What should patients pay attention to when taking it?
2026-02-01 22:25:32
Check Details
Which class of antibacterial drugs does clofazimine belong to? What are its mechanisms of action and indications?
2026-02-01 22:25:32
Check Details
What is the usage and dosage of gosatuzumab (Todavi)? How to take it correctly according to the doctor's advice?
2026-02-01 22:25:32
Check Details
How to buy evantumumab? How can patients obtain this drug?
2026-02-01 22:25:32
Check Details
How does Glasgib/Glasgib compare to traditional chemotherapy drugs?
2026-02-01 22:25:32
Check Details
Real-world data supports first-line use of avelumab plus axitinib/axitinib in advanced renal cell carcinoma
2026-02-01 22:25:32
Check Details
Duration of use of trametinib and dabrafenib and related precautions
2026-02-01 22:25:32
Check Details
1
2
...
1400
1401
1402
1403
1404
1405
1406
...
10226
10227
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
2
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
3
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
4
Cabergoline Medication Guide: Contraindications, Treatment Costs, and Safety Monitoring Essentials
5
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
6
Enasidenib (IDHIFA): A Comprehensive Guide to Targeted Therapy for IDH2-Mutated Acute Myeloid Leukemia
7
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
8
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
9
Filgotinib: Mechanism of Action and Clinical Applications Explained
10
Lapatinib: Proper Administration Guide and Key Precautions
11
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
12
Cemiplimab Storage and Handling Guide